Article Details

AstraZeneca: CHMP Recommends Beyfortus For EU Approval - Quick Facts - RTTNews

Retrieved on: 2022-09-16 10:05:23

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca: CHMP Recommends Beyfortus For EU Approval - Quick Facts - RTTNews. View article details on hiswai:

Excerpt

British drug major AstraZeneca plc (AZN.L, AZN) announced Friday that Beyfortus (nirsevimab) has been recommended for marketing authorisation in ...

Article found on: www.rttnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up